Revenue
2023
AVAI BIO, INC. (AVAI)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $276,324 | — | — | — | — |
| Gross profit | — | — | — | −$40,453 | −$210,794 | −$16,536 | −$256,334 | $0 |
| Research & development | $15,000 | — | — | — | — | — | $27,040 | $0 |
| Operating expenses | $1.5M | $1.5M | $2.1M | $323,131 | $553,920 | $287,188 | $325,927 | $78,225 |
| Operating income | −$1.7M | −$1.1M | −$2.1M | −$348,933 | $126,521 | $302,292 | $69,593 | −$78,225 |
| EBITDAderived | −$1.7M | −$1.1M | −$2.1M | −$325,516 | — | — | $108,695 | −$73,423 |
| Net income | −$1.7M | −$1.1M | −$2.1M | −$348,933 | −$126,521 | −$302,292 | −$69,593 | −$78,225 |
| Basic EPSper diluted share | -$0.01 | -$0.01 | -$0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | — | — | — | — | — | — | $0.00 | $0.00 |